2019ESPGHAN意见书：婴幼儿配方奶粉中棕榈油和β棕榈酸酯.pdf

SOCIETY PAPER Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition ÃJiri Bronsky, yCristina Campoy, zNicholas Embleton, §Mary Fewtrell, ˇ jj Ãà yy Natas a Fidler Mis, Konstantinos Gerasimidis, Iva Hojsak, Jessie Hulst, zzFlavia Indrio, §§Alexandre Lapillonne, jjjjÃÃÃChristian Molgaard, yyySissel Jennifer Moltu, zzzElvira Verduci, §§§Rakesh Vora, and Magnus Domellof, ESPGHAN Committee on Nutrition ¨ ABSTRACT Background: Palm oil (PO) is used in infant formulas in order to achieve What Is Known palmitic acid (PA) levels similar to those in human milk. PA in PO is esterified predominantly at the SN-1,3 position of triacylglycerol (TAG),  Palm oil is used as source of fat in infant formula in and infant formulas are now available in which a greater proportion of PA is in the SN-2 position (typical configuration in human milk). As there are order to achieve palmitic acid levels comparable to human milk. some concerns about the use of PO, we aimed to review literature on health effects of PO and SN-2-palmitate in infant formulas.  Palmitic acid in human milk is predominantly at the